Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fanavari Daroei va Sakht Arayeh Negar is an Iranian knowledge-based pharmaceutical company specializing in advanced drug delivery systems and nanotechnology. The company is best known for developing and manufacturing complex formulations, including albumin-bound nanoparticles and liposomal injections. Its flagship products include Paclinab (nanoparticle albumin-bound paclitaxel) and liposomal doxorubicin, targeting various oncology indications. Arayeh Negar operates within the Iranian biotech ecosystem, focusing on high-tech imports substitution and providing affordable access to specialized medicines. The firm maintains strong ties with academic institutions and the Barakat Pharmaceutical Group to drive innovation in the domestic life sciences sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fanavari Daroei va Sakht Arayeh Negar Company.